Delivery Order SPE2DB20D1109-SPE2DB25FN92F

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication, with a ceiling value of $1,079.95. The contract is a firm fixed-price delivery order with a period of performance through March 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a prescription medication. The contract has a ceiling value of $47,555.04 and a period of performance through April 14, 2025. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a prescription medication. The contract has a ceiling value of $2,680.50 and a period of performance through January 7, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,673.57, is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a medication. The contract has an ultimate completion date of April 9, 2025 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a ceiling value of $1,256.40 and an ultimate completion date of June 17, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024. The contract has a firm fixed price of $2,359.95 and an ultimate completion date of December 31, 2024. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a medication used in the treatment of Parkinson's disease. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA Troop Support Medical) to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,087.98 and a performance period ending on March 12, 2024. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription pharmaceutical product. No set-aside designation was used for this...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,774.34, is for the supply of RYTARY ER 36.25 MG-145 MG capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This is a $9,682.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the pharmaceutical product RYTARY ER 23.75 MG-95 MG CAP 100S. There is no set-aside designation, indicating open competition for the award. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $5,289.56 and covers the supply of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication, with a period of performance through March 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN92F
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication RYTARY ER 23.75 MG-95 MG CAP 100S. The contract has a ceiling value of $4,340.30 and a period of performance through April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp, as the prime contractor, is responsible for supplying the specified medication to support military and government healthcare programs.

Generated 7/18/25, 10:07 AM